4//SEC Filing
Ridloff Elena 4
Accession 0000950170-25-090579
CIK 0001815442other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 9:00 PM ET
Size
5.3 KB
Accession
0000950170-25-090579
Insider Transaction Report
Form 4
Ridloff Elena
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 totalExercise: $46.47Exp: 2035-06-24→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 25, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001772518
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 9:00 PM ET
- Size
- 5.3 KB